Ranok Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series B1
- Latest Deal Amount
-
$5M
- Investors
-
6
Ranok Therapeutics General Information
Description
Developer of clinical-stage biopharmaceuticals designed for the discovery and development of novel therapeutics. The company's technology utilises a proprietary chaperone-mediated protein degradation platform and a chaperone-tether library to regulate protein folding and stability, providing oncology patients with targeted therapies that selectively degrade disease-causing proteins in tumours while minimising impact on healthy tissues.
Contact Information
Website
www.ranoktherapeutics.comCorporate Office
- Floor 4, Building 16, Hexiang Science and Technology Center
- Qiantang District
- Hangzhou, Zhejiang 310020
- China
Corporate Office
- Floor 4, Building 16, Hexiang Science and Technology Center
- Qiantang District
- Hangzhou, Zhejiang 310020
- China
Ranok Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series B1) | 09-Jan-2023 | $5M | Completed | Generating Revenue | ||
| 5. Secondary Transaction - Private | 02-Apr-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 15-Jul-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Nov-2020 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | 23-Dec-2019 | $2M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Apr-2019 | $2M | $2M | Completed | Startup |
Ranok Therapeutics Signals
Ranok Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hyfinity Investments | Growth/Expansion | Minority | ||
| Platanus | Family Office | Minority | ||
| Ling Cheng Ventures | Growth/Expansion | Minority | ||
| Med-Fine Capital | Venture Capital | Minority | ||
| TF Capital | Venture Capital | Minority |
Ranok Therapeutics FAQs
-
When was Ranok Therapeutics founded?
Ranok Therapeutics was founded in 2018.
-
Where is Ranok Therapeutics headquartered?
Ranok Therapeutics is headquartered in Hangzhou, China.
-
What is the size of Ranok Therapeutics?
Ranok Therapeutics has 30 total employees.
-
What industry is Ranok Therapeutics in?
Ranok Therapeutics’s primary industry is Drug Discovery.
-
Is Ranok Therapeutics a private or public company?
Ranok Therapeutics is a Private company.
-
What is Ranok Therapeutics’s current revenue?
The current revenue for Ranok Therapeutics is .
-
How much funding has Ranok Therapeutics raised over time?
Ranok Therapeutics has raised $55M.
-
Who are Ranok Therapeutics’s investors?
Hyfinity Investments, Platanus, Ling Cheng Ventures, Med-Fine Capital, and TF Capital are 5 of 6 investors who have invested in Ranok Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process